What is Iovance Biotherapeutics, Inc.'s inventory turnover?

Iovance Biotherapeutics, Inc. (IOVA) reported inventory turnover of 2.9× in Q1 2026.

How has Iovance Biotherapeutics, Inc.'s inventory turnover changed year-over-year?

Iovance Biotherapeutics, Inc.'s inventory turnover decreased by 15.4% year-over-year, from 3.4× to 2.9×.

What does inventory turnover mean?

Trailing-twelve-month cost of revenue divided by average inventory. Measures how many times inventory is sold and replaced over the year.

Iovance Biotherapeutics, Inc. IOVA Inventory turnover

Inventory turnover at other companies

Bristol-Myers SquibbBMY

5.3×+0.3×

Gilead SciencesGILD

2.8×-0.8×

ImmunityBio, Inc.IBRX

0.1×—

IncyteINCY

1.2×+0.1×

Nektar TherapeuticsNKTR

2.2×+0.8×

BiogenBIIB

19×-3.6×

Other financials

Income statement

See full

Revenue$71.4M+44.8%

Gross profit$28.9M+338%

Operating income-$81.0M+33.1%

Net income-$79.0M+32.0%

EPS (diluted)-$0.19+47.2%

Balance sheet

See full

Cash & equivalents$196.5M+14.5%

Total debt$46.8M-11.3%

Total equity$721.8M-6.0%

Total assets$925.7M-4.2%

Cash flow

See full

Operating cash flow-$72.1M+30.5%

CapEx$6.6M+6.4%

Free cash flow-$78.7M+28.4%

Valuation

See full

Market cap$1.98B+32.4%

Enterprise value$1.83B+33.2%

P/S6.9×-0.1×

Profitability

See full

Gross margin36.7%+4.1pp

Operating margin-127.2%-31.0pp

Net margin-123.9%-28.4pp

FCF margin-106.8%-27.5pp

Returns & leverage

See full

Return on equity-47.5%-3.7pp

Debt / equity0.1×0.0×

Current ratio3.6×-0.6×

Where this comes from

Calculated from Iovance Biotherapeutics, Inc.’s reported figures.

total cost of revenue/inventories=2.9×

Based on trailing twelve months.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s inventory turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s inventory turnover?: Iovance Biotherapeutics, Inc. (IOVA) reported inventory turnover of 2.9× in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s inventory turnover changed year-over-year?: Iovance Biotherapeutics, Inc.'s inventory turnover decreased by 15.4% year-over-year, from 3.4× to 2.9×.
What does inventory turnover mean?: Trailing-twelve-month cost of revenue divided by average inventory. Measures how many times inventory is sold and replaced over the year.